Common biomarkers include PD-L1 expression, MSI/mismatch repair status, tumor mutational burden, and circulating tumor DNA, but some potential biomarkers, such as peripheral blood inflammation markers, tumor markers, and nutritional status, remain controversial. Here, CD274 is linked to neoplasm.